The Human Variable 

Explore 25+ Long COVID phenotypes including POTS, PEM, viral persistence, and brain fog. A clinical framework for research, trials, and personalized care pathways.

Public health research following Hurricane Katrina, the Fukushima nuclear disaster, and other major events has shown that individuals with chronic health conditions often experience disproportionate impacts during crises due to disrupted medical care, environmental exposures, and infrastructure breakdowns. Understanding the size and characteristics of medically vulnerable populations is therefore essential for accurate disaster preparedness planning.

P.R.O.O.F. GPT™ was developed to support harm-aware analysis in complex systems. P.R.O.O.F. stands for People Revealing Overlooked & Outdated Failures. The system applies the Moral Adinig Method to identify omissions, delays, representation gaps, and outdated assumptions that increase risk exposure. Its purpose is not to assign blame or rank vulnerability, but to improve system reliability and safeguard design.

Most medical care is built for short illnesses. A problem appears, treatment begins, and recovery is expected to follow a steady path. Infection-associated chronic conditions do not behave this way. Symptoms can change day to day, worsen after delays, and affect multiple body systems even when routine tests look normal. This mismatch often leads to misunderstanding or dismissal of patient experiences

When corrected through the US-CCUC™ framework, the combined burden of the ten most prominent infection-associated chronic conditions is estimated to affect approximately 75–90 million Americans, with 25–35 million individuals experiencing multiple overlapping conditions. Long COVID alone likely affects a population approaching 65 million adults over time when accounting for diagnostic undercounting and relapsing disease trajectories.

Long COVID, a debilitating condition impacting an estimated 35–50 million Americans, including 4–6 million with severe impairments and 2–5 million children, demands a robust diagnostic framework to address its complex, multi-system symptoms. The Composite Diagnostic Fingerprint (CDF) offers a validated, high-specificity approach, integrating 12 biomarkers across immunological, neurological, cardiovascular, and metabolic systems, enhanced by digital phenotyping.